Atara Biotherapeutics, Inc. (ATRA)
Biotechnology · Healthcare · $86M
Intrinsic Value (Consensus)
$41.43
Current Price
$10.09
Margin of Safety
+300%
300% Below Intrinsic Value
Value: $41
Price: $10
Valuation Model Estimates
Current Price: $10.09
DCF (Discounted Cash Flow)
$155.93
Graham Number
Not applicable
—
Earnings Power Value
$35.21
Relative Value (P/E)
$47.65
Dividend Discount Model
Not applicable
—
Consensus Value
$41.43
Model Assumptions
Discount Rate
10.3%
Growth Rate
18.5%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
50
Profitability
10/25
Strength
8/25
Valuation
22/25
Growth
10/25
Financial Health Signals
Negative free cash flow — company is burning cash
Declining revenue — top line is shrinking
Strong earnings growth (19% YoY)
Key Financials
- EPS (TTM)
- $2.57
- EPS (Forward)
- $2.70
- Book Value
- $-4.52
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- N/A
- Debt/Equity
- —
- Revenue Growth
- -6.3%
- Earnings Growth
- 18.5%
- Dividend Yield
- N/A
- Beta
- 0.12
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
NVAXNOVAVAX INC
$36.38+295.4%
Data last updated: 2026-06-21
Source: Yahoo Finance